According to Viridian Therapeutics's latest financial reports the company's current earnings (TTM) are -HK$1.76 B. In 2023 the company made an earning of -HK$1.84 B a decrease over its 2022 earnings that were of -HK$1.01 B.The earnings displayed on this page is the company's Pretax Income.